From: Overexpression of MACC1 and Its significance in human Breast Cancer Progression
 | Univariate analysis | Multivariate | ||
---|---|---|---|---|
 | P | Hazard ratio (95% CI) | P | Hazard ratio (95% CI) |
Age | Â | Â | Â | Â |
 ≤45 | 0.261 | 0.709 (0.389-1.291) |  |  |
 >45 |  |  |  |  |
Menopausal status | 0.589 | 1.223 (0.590-2.534) | Â | Â |
Premenopausal | Â | Â | Â | Â |
Postmenopausal | Â | Â | Â | Â |
Tumor size (cm) | Â | Â | Â | Â |
 ≤2 | <0.001 | 5.930 (2.501-14.064) | 0.027 | 2.833(1.125-7.132) |
 >2 | ||||
Lymph node status | Â | Â | Â | Â |
 Negative | <0.001 | 5.581 (2.674-11.648) | 0.001 | 3.836(1.786-8.239) |
 Positive | ||||
ER | Â | Â | Â | Â |
 Positive | 0.11 | 0.458 (0.251-0.836) | 0.044 | 0.534 (0.290-0.983) |
 Negative | ||||
PR | Â | Â | Â | Â |
 Positive | 0.076 | 0.557 (0.292-1.064) |  |  |
 Negative | ||||
ErbB-2 | Â | Â | Â | Â |
 Positive | 0.837 | 1.101 (0.440-2.758) |  |  |
 Negative | ||||
MACC1 expression | Â | Â | Â | Â |
 Positive | 0.001 | 3.682 (1.756-7.721) | 0.010 | 2.730(1.277-5.839) |
 Negative |